References
- Brooke, B. S., A. Bayes-Genis, and D. Y. Li. 2003. New insights into elastin and vascular disease. Trends Cardiovasc. Med. 13: 176-181 https://doi.org/10.1016/S1050-1738(03)00065-3
- Doi, K., T. Horiuchi, M. Uchinami, T. Tabo, N. Kimura, J. Yokomachi, M. Yoshida, and K. Tanaka. 2002. Neutrophil elastase inhibitor reduces hepatic metastases induced by ischaemia reperfusion in rats. Eur. J. Surg. 168: 507-510 https://doi.org/10.1080/110241502321116541
- Elastin Products Company. 2004. Research Biochemical Catalogue. Missouri, USA, pp. 11-14
- Jung, H. I., S. I. Kim, K. S. Ha, C. O. Joe, and K.-W Kang. 1995. Isolation and characterization of guamerin, a new human leukocyte elastase inhibitor from Hirudo nipponia. J. Biol. Chem. 270: 13879-13884 https://doi.org/10.1074/jbc.270.23.13879
- Kim, K.-Y., H.-K. Lim, K.-J. Lee, D.-H. Park, K.-W Kang, S.-I. Chung, and K.-H. Jung. 2000. Production and characterization of recombinant guamerin, and elastasespecific inhibitor, in methylotrophic yeast Pichia pastoris. Protein Expr. Purif. 20: 1-9 https://doi.org/10.1006/prep.2000.1300
- Lee, H. S., W. J. Jin, S. G. Kang, Y. S. Hwang, Y. H. Kho, and K. J. Lee. 2000. Characterization of an elastase inhibitor produced by Streptomyces lavendulae SMF11. J. Microbiol. Biotechnol. 10: 81 -85
- Lee, J.-L., S.-N. Yang, C.-S. Park, D. Jeoung, and H.-Y. Kim. 2004. Purification and glycosylation pattern of human L-ferritin in Pichia pastoris. J. Microbiol. Biotechnol. 14: 68-73
- Lim, H.-K., K.-Y. Kim, K.-J. Lee, D.-H. Park, S.-I. Chung, and K.-H. Jung. 2000. Genetic stability of integrated structural gene of guamerin in recombinant Pichia pastor is. J. Microbiol. Biotechnol. 10: 470-475
- Lim, H.-K., S.-J. Choi, K.-Y Kim, and K.-H. Jung. 2003. DO-stat controlling two variables for the methanol induction of rGuamerin in Pichia pastoris and its application to repeated fed-batch. Appl. Microbiol. Biotechnol. 62: 342-348 https://doi.org/10.1007/s00253-003-1307-6
- Nozawa, F., M. Hirota, A. Okabe, M. Shibata, T. Iwamura, Y. Haga, and M. Ogawa. 2000. Elastase activity enhances the adhesion of neutrophil and cancer cells to vascular endothelial cells. J. Surg. Res. 94: 153-158 https://doi.org/10.1006/jsre.2000.6002
- Parka, J. Y, L. Chena, J. Leeb, T. Sellersa, and M. S. Tockmana. 2005. Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk. Lung Cancer 48: 315-321 https://doi.org/10.1016/j.lungcan.2004.11.022
- Ro, H.-S., M.-S. Lee, M.-S. Hahm, H.-S. Bae, and B. H. Chung. 2005. Production of active carboxypeptidase Y of Saccharomyces cerevisiae secreted from methylotrophic yeast Pichia pastoris. J. Microbiol. Biotechnol. 15: 202-205
- Robert, L., A. M. Robert, and B. Jacotot. 1998. Elastinelastase-atherosclerosis revisited. Atherosclerosis 140: 281-295 https://doi.org/10.1016/S0021-9150(98)00171-3
- Shapiro, S. D. 2002. Neutrophil elastase: Path clearer, pathogen killer, or just pathologic? Am. J Respir. Cell Mol. BioI. 26: 266-268 https://doi.org/10.1165/ajrcmb.26.3.f233
- Sun, Z. and P. Yang. 2004. Role of imbalance between neutrophil elastase and ai-antitrypsin in cancer development and progression. Lancet Oncol. 5: 182-190 https://doi.org/10.1016/S1470-2045(04)01414-7
- Taniguchi, K., P. Yang, J. lett, E. Bass, R. Meyer, Y. Wang, C. Deschamps, and W. Liu. 2002. Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development. Clin. Cancer Res. 8: 1115-1120
- Tremblay, G. M., M. F. Janelle, and Y. Bourbonnais. 2003. Anti-inflammatory activity of neutrophil elastase inhibitors. Curr. Opin. Investig. Drugs 4: 556-565
- Zureik, M., L. Robert, D. Courbon, P.-J. Touboul, L. Bizbiz, and P. Ducirnetiere, 2002. Serum elastase activity, serum elastase inhibitors, and occurrence of carotid atherosclerotic plaques. Circulation 105: 2638-2645 https://doi.org/10.1161/01.CIR.0000017329.51160.EF